\
&
Contact us
Published on | 8 months ago
Programmes Digital, Industry & SpaceThe HORIZON-SESAR-2025 calls are part of the Horizon Europe programme, aimed at funding projects that strengthen the European Digital Sky.
Coordinated by the SESAR 3 Joint Undertaking, they drive the transformation of the Air Traffic Management (ATM) system through disruptive technologies, advanced automation, and environmental solutions.
These calls seek not only to improve the efficiency of Europe’s airspace but also to reduce aviation’s environmental footprint, optimise air navigation services, and ensure a safe transition towards future air mobility.
The HORIZON-SESAR-2025 calls target:
Transnational cooperation is prioritised to strengthen the European Research Area in air traffic management and innovative air mobility.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
AI Continent Deployment: Best use of technologies
The European Commission has published the recording and presentations from its 18 December 2025 info session on the call topics Data Space for Manufacturing (DIGITAL-2026-DSM-AI-09-DS-MANUFACTUR-STEP) and European Digital Media Observatory hubs (DIGITAL-2026-BESTUSE-TECH-EDMO-09-HUBS). The slides and recording are available on ... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.